Just this week, DEA agents raided two medical marijuana dispensaries in San Diego. The raid came one day after the owner of one of the facilities testified at a city council hearing on regulations for medical marijuana dispensaries.
Ironically, it also comes as the Obama administration announces their new drug control strategy, which they call a “21st century approach to drug policy.” To hear them tell it, we’re now focused on treatment and prevention rather than arrests and prosecutions. Of course, that’s not true, and no one knows that better than medical marijuana providers in California and elsewhere. Fortunately, there is a way to change all that.
Congressman Earl Blumenauer (D-OR) has introduced the States’ Medical Marijuana Patient Protection Act. If passed, his bill would reschedule marijuana, recognizing its medical value, and prevent the DEA from going after patients, doctors, or dispensaries.
It’s vital that your representatives in Congress know that you support medical marijuana and that people who provide doctor-recommended medicine to sick people are not criminals. Please write your elected officials today, and when you’re done, forward this to friends so they can do the same.
Early last week, a group of former DEA administrators released a statement calling on the Department of Justice to prevent Colorado and Washington from implementing new marijuana regulations in accordance with laws passed in those states in November. In an article published later that week, the magazine explored the possibility that some of the signatories of that statement may have something to gain from keeping marijuana illegal:
Two of the former Drug Enforcement Agency officials who came out this week urging the federal government to nullify new state pot laws in Washington and Colorado are facing criticism for simultaneously running a company that may profit from keeping marijuana illegal.
Robert L. DuPont, who was White House drug czar under Presidents Nixon and Ford, and Peter Bensinger, who was administrator of the Drug Enforcement Administration in the 1970s, today run Bensinger, DuPont & Associates, a company that specializes in workplace drug testing, among other employee programs.
There’s some big news coming out of Washington, D.C.: On Tuesday, congressmen from Oregon and Colorado introduced two historic federal marijuana reform bills to Congress.
Rep. Jared Polis (D-CO) introduced the Ending Federal Marijuana Prohibition Act of 2013. If passed, the bill would remove marijuana from Schedule I of the Controlled Substances Act and institute a system similar to the alcohol regulatory structure that federally regulates marijuana. It would also transfer jurisdiction over marijuana from the Drug Enforcement Administration (DEA) to a newly renamed Bureau of Alcohol, Tobacco, Marijuana, Firearms, and Explosives.
Rep. Earl Blumenauer (D-OR) introduced the Marijuana Tax Equity Act, which calls for an excise tax of marijuana at the federal level. It also requires the IRS to develop a steady understanding of the industry. After the first two years, and every five years following, the IRS would produce a study of the trade, offering recommendations to Congress so as to improve upon the administration of the tax. Who ever thought that the words “IRS” and “taxes” would be cause for celebration?
The introduction of these bills was largely inspired by the passage of legalization initiatives last November in Colorado – where MPP provided most of the funding for the campaign – and in Washington state.
Today is a notable occasion. It is the 30th anniversary of a Florida man gaining the ability to use marijuana for medical purposes and of the beginning of a bafflingly hypocritical stance by the federal government.
One of the strangest ironies in the government’s war on marijuana is demonstrated by a man named Irv Rosenfeld. The federal authorities still officially maintain the legal fiction that marijuana has no accepted medical use; the substance is still classified in Schedule I, and medical marijuana providers are still raided and prosecuted by the DEA. Yet, the federal government has been producing and delivering marijuana to Rosenfeld for decades. Rosenfeld suffers from a rare bone disorder, multiple congenital cartilaginous exostoses, in which cancerous spurs of bone grow outward through his body, causing extreme pain and necessitating six surgeries to date. To treat his condition, he receives approximately 300 pre-rolled marijuana cigarettes from the federal government every 25 days.
The marijuana is produced at the University of Mississippi as part of the Compassionate Investigational New Drug program. This program, administered by the National Institute on Drug Abuse, was first established in response to the successful lawsuit against the government on behalf of Robert Randall. Randall, a glaucoma patient, was arrested for growing his own medicine in 1975, but successfully employed a “medical necessity” defense. Since it was established that marijuana was the only medicine that worked to control his glaucoma, it was argued that any sensible person in such a situation would violate the marijuana laws rather than allowing themselves to go blind. The program currently supplies medical marijuana to only four known surviving patients; it was closed to new applicants by the first Bush administration in 1991, rejecting hundreds of already filed applications.
Rosenfeld works as a stockbroker. Contrary to official innuendo about the incapacitating effects of the marijuana “high,” he shows all signs of being fully functional while smoking 10-12 joints per day. Federal anti-drug authorities show no interest in studying his case, while simultaneously complaining of the lack of evidence for the medical efficacy or safety of smoked marijuana. They are apparently also not concerned with the 1988 ruling of the DEA’s own Chief Administrative Law Judge, Francis Young, who found that “marijuana has been accepted as capable of relieving the distress of great numbers of very ill people” and is “one of the safest therapeutically active substances known to man.” The federal government even holds a patent for the medical use of cannabinoids, chemicals found in marijuana.
Rosenfeld will be in Illinois from Tuesday through Thursday of next week, in support of the medical marijuana bill under consideration in the state legislature. Anyone interested in interviewing him should contact Morgan Fox, either through email at firstname.lastname@example.org or by phone at 202-905-2031.